Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose value of the neonate at birth. Secondary Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Infrequent | Patients will undergo one fingerstick on admission for their labor process. |
| |
| Frequent | Patients will undergo fingersticks every 4 hours in latent labor and 2 hour in active labor during their labor process. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fingerstick | Other | fingersticks during their labor process |
|
| Measure | Description | Time Frame |
|---|---|---|
| Neonatal glucose level | at 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Number of neonates requiring insulin | at 24 hours | |
| Number of NICU admissions | at 24 hours | |
| Number of glucose treatments |
Not provided
Inclusion Criteria:
All female patients of reproductive age (menarche-menopause: 18-51 years) who have the diagnosis diet controlled GDM
Patient with singleton gestation presenting in labor or for induction
Patients who had "good" glucose control and were A1GDM. Good Control;
Exclusion Criteria:
• If patient's admission accu check is >120
Not provided
Not provided
Patient with A1GDM (diet controlled gestational diabetes)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Owens, MD | Mount Sinai West | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mount Sinai West | New York | New York | 10019 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
Not provided
Not provided
Not provided
Not provided
Not provided
| at 24 hours |
| Number of neonatal with hyperbilirubinemia | at 24 hours |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |